Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Toll-like Interleukin 1 Receptor Regulator Is an Important Modulator of Inflammation Responsive Genes.

Kashem MA, Li H, Toledo NP, Omange RW, Liang B, Liu LR, Li L, Yang X, Yuan XY, Kindrachuk J, Plummer FA, Luo M.

Front Immunol. 2019 Feb 28;10:272. doi: 10.3389/fimmu.2019.00272. eCollection 2019.

2.

A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918-1919.

Nickol ME, Kindrachuk J.

BMC Infect Dis. 2019 Feb 6;19(1):117. doi: 10.1186/s12879-019-3750-8. Review.

3.
4.

Persistence and Sexual Transmission of Filoviruses.

Schindell BG, Webb AL, Kindrachuk J.

Viruses. 2018 Dec 2;10(12). pii: E683. doi: 10.3390/v10120683. Review.

5.

Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.

Dyall J, Gross R, Kindrachuk J, Johnson RF, Olinger GG Jr, Hensley LE, Frieman MB, Jahrling PB.

Drugs. 2017 Dec;77(18):1935-1966. doi: 10.1007/s40265-017-0830-1. Review.

6.

Selective inhibition of host cell signaling for rotavirus antivirals: PI3K/Akt/mTOR-mediated rotavirus pathogenesis.

Kindrachuk J.

Virulence. 2018 Jan 1;9(1):5-8. doi: 10.1080/21505594.2017.1356539. Epub 2017 Aug 18. No abstract available.

7.

Evidence of Ebola Virus Replication and High Concentration in Semen of a Patient During Recovery.

Barnes KG, Kindrachuk J, Lin AE, Wohl S, Qu J, Tostenson SD, Dorman WR, Busby M, Siddle KJ, Luo CY, Matranga CB, Davey RT, Sabeti PC, Chertow DS.

Clin Infect Dis. 2017 Oct 15;65(8):1400-1403. doi: 10.1093/cid/cix518.

8.

Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.

Kash JC, Walters KA, Kindrachuk J, Baxter D, Scherler K, Janosko KB, Adams RD, Herbert AS, James RM, Stonier SW, Memoli MJ, Dye JM, Davey RT Jr, Chertow DS, Taubenberger JK.

Sci Transl Med. 2017 Apr 12;9(385). pii: eaai9321. doi: 10.1126/scitranslmed.aai9321.

9.
10.

1918 Influenza receptor binding domain variants bind and replicate in primary human airway cells regardless of receptor specificity.

Davis AS, Chertow DS, Kindrachuk J, Qi L, Schwartzman LM, Suzich J, Alsaaty S, Logun C, Shelhamer JH, Taubenberger JK.

Virology. 2016 Jun;493:238-46. doi: 10.1016/j.virol.2016.03.025. Epub 2016 Apr 11.

11.

Influenza A and methicillin-resistant Staphylococcus aureus co-infection in rhesus macaques - A model of severe pneumonia.

Chertow DS, Kindrachuk J, Sheng ZM, Pujanauski LM, Cooper K, Nogee D, Claire MS, Solomon J, Perry D, Sayre P, Janosko KB, Lackemeyer MG, Bohannon JK, Kash JC, Jahrling PB, Taubenberger JK.

Antiviral Res. 2016 May;129:120-129. doi: 10.1016/j.antiviral.2016.02.013. Epub 2016 Feb 26.

12.

1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans.

Walters KA, D'Agnillo F, Sheng ZM, Kindrachuk J, Schwartzman LM, Kuestner RE, Chertow DS, Golding BT, Taubenberger JK, Kash JC.

J Pathol. 2016 Jan;238(1):85-97. doi: 10.1002/path.4638. Epub 2015 Oct 14.

13.

Characterization of the host response to pichinde virus infection in the Syrian golden hamster by species-specific kinome analysis.

Falcinelli S, Gowen BB, Trost B, Napper S, Kusalik A, Johnson RF, Safronetz D, Prescott J, Wahl-Jensen V, Jahrling PB, Kindrachuk J.

Mol Cell Proteomics. 2015 Mar;14(3):646-57. doi: 10.1074/mcp.M114.045443. Epub 2015 Jan 8.

14.

Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis.

Kindrachuk J, Ork B, Hart BJ, Mazur S, Holbrook MR, Frieman MB, Traynor D, Johnson RF, Dyall J, Kuhn JH, Olinger GG, Hensley LE, Jahrling PB.

Antimicrob Agents Chemother. 2015 Feb;59(2):1088-99. doi: 10.1128/AAC.03659-14. Epub 2014 Dec 8.

15.

Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.

Kuhn JH, Andersen KG, Bào Y, Bavari S, Becker S, Bennett RS, Bergman NH, Blinkova O, Bradfute S, Brister JR, Bukreyev A, Chandran K, Chepurnov AA, Davey RA, Dietzgen RG, Doggett NA, Dolnik O, Dye JM, Enterlein S, Fenimore PW, Formenty P, Freiberg AN, Garry RF, Garza NL, Gire SK, Gonzalez JP, Griffiths A, Happi CT, Hensley LE, Herbert AS, Hevey MC, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson JC, Johnson KM, Kindrachuk J, Klenk HD, Kobinger G, Kochel TJ, Lackemeyer MG, Lackner DF, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Omilabu SA, Palacios G, Panchal RG, Park DJ, Patterson JL, Paweska JT, Peters CJ, Pettitt J, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Sabeti PC, Sealfon R, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Viruses. 2014 Sep 26;6(9):3663-82. doi: 10.3390/v6093663.

16.

Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes.

Kindrachuk J, Wahl-Jensen V, Safronetz D, Trost B, Hoenen T, Arsenault R, Feldmann F, Traynor D, Postnikova E, Kusalik A, Napper S, Blaney JE, Feldmann H, Jahrling PB.

J Virol. 2014 Sep 1;88(17):9877-92. doi: 10.1128/JVI.01410-14. Epub 2014 Jun 18.

17.

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.

Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, Johnson RF, Olinger GG Jr, Jahrling PB, Laidlaw M, Johansen LM, Lear-Rooney CM, Glass PJ, Hensley LE, Frieman MB.

Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93. doi: 10.1128/AAC.03036-14. Epub 2014 May 19.

18.

The NIAID Integrated Research Facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL-4 pathogens.

Jahrling PB, Keith L, St Claire M, Johnson RF, Bollinger L, Lackemeyer MG, Hensley LE, Kindrachuk J, Kuhn JH.

Pathog Dis. 2014 Jul;71(2):213-9. doi: 10.1111/2049-632X.12171. Epub 2014 May 8. Review.

19.

Systems kinomics for characterizing host responses to high-consequence pathogens at the NIH/NIAID Integrated Research Facility-Frederick.

Kindrachuk J, Falcinelli S, Wada J, Kuhn JH, Hensley LE, Jahrling PB.

Pathog Dis. 2014 Jul;71(2):190-98. doi: 10.1111/2049-632X.12163. Epub 2014 Apr 10. Review.

20.

ABSL-4 aerobiology biosafety and technology at the NIH/NIAID integrated research facility at Fort Detrick.

Lackemeyer MG, Kok-Mercado Fd, Wada J, Bollinger L, Kindrachuk J, Wahl-Jensen V, Kuhn JH, Jahrling PB.

Viruses. 2014 Jan 7;6(1):137-50. doi: 10.3390/v6010137.

Supplemental Content

Loading ...
Support Center